Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sima Rafati

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Plos Neglected Tropical Diseases|February 28, 2019
Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentialsFarnaz Zahedifard, Hyeryon Lee, Joo Hwan No, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 25, 2010
Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluationsDelaram Doroud, Alireza Vatanara, Farnaz Zahedifard, et al.
Veterinary Parasitology|January 30, 2004
Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected populationAlireza Nakhaee, Tahere Taheri, Mohammad Taghikhani, et al.
Experimental Parasitology|December 22, 2019
Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasiteFarnaz Zahedifard, Hyeryon Lee, Joo Hwan No, et al.
Vaccine|October 13, 2009
Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasisAmir Mizbani, Tahereh Taheri, Farnaz Zahedifard, et al.
Experimental Parasitology|February 1, 2015
Generation of stable L. major(+EGFP-LUC) and simultaneous comparison between EGFP and luciferase sensitivityTahereh Taheri, Hana Saberi Nik, Negar Seyed, et al.
Molecular Immunology|May 14, 2015
Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimenMaryam Golshani, Sima Rafati, Seyed Davar Siadat, et al.
Journal of Biomolecular Structure & Dynamics|September 28, 2020
Computational evaluation of modified peptides from human neutrophil peptide 1 (HNP-1)Neda Moazzezy, Elham Rismani, Maryam Rezaei, et al.
Journal of Breast Cancer|April 12, 2016
Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene TherapyYasaman Taslimi, Farnaz Zahedifard, Sima Habibzadeh, et al.
Scientific Reports|May 20, 2026
Bulky pcDNA plasmid encoding Leishmania- and Sandfly-derived antigens resulted in transient Th1 response post Leishmania major infection in BALB/c miceNegar Seyed, Hamzeh Sarvnaz, Sima Habibzadeh, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Plos Neglected Tropical Diseases|February 28, 2019
Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentialsFarnaz Zahedifard, Hyeryon Lee, Joo Hwan No, et al.
Journal of Pharmacy & Pharmaceutical Sciences : a Publication of the Canadian Society for Pharmaceutical Sciences, Societe Canadienne Des Sciences Pharmaceutiques|November 25, 2010
Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluationsDelaram Doroud, Alireza Vatanara, Farnaz Zahedifard, et al.
Veterinary Parasitology|January 30, 2004
Humoral and cellular immune responses against Type I cysteine proteinase of Leishmania infantum are higher in asymptomatic than symptomatic dogs selected from a naturally infected populationAlireza Nakhaee, Tahere Taheri, Mohammad Taghikhani, et al.
Experimental Parasitology|December 22, 2019
Comparative study of different forms of Jellein antimicrobial peptide on Leishmania parasiteFarnaz Zahedifard, Hyeryon Lee, Joo Hwan No, et al.
Vaccine|October 13, 2009
Recombinant Leishmania tarentolae expressing the A2 virulence gene as a novel candidate vaccine against visceral leishmaniasisAmir Mizbani, Tahereh Taheri, Farnaz Zahedifard, et al.
Experimental Parasitology|February 1, 2015
Generation of stable L. major(+EGFP-LUC) and simultaneous comparison between EGFP and luciferase sensitivityTahereh Taheri, Hana Saberi Nik, Negar Seyed, et al.
Molecular Immunology|May 14, 2015
Improved immunogenicity and protective efficacy of a divalent DNA vaccine encoding Brucella L7/L12-truncated Omp31 fusion protein by a DNA priming and protein boosting regimenMaryam Golshani, Sima Rafati, Seyed Davar Siadat, et al.
Journal of Biomolecular Structure & Dynamics|September 28, 2020
Computational evaluation of modified peptides from human neutrophil peptide 1 (HNP-1)Neda Moazzezy, Elham Rismani, Maryam Rezaei, et al.
Journal of Breast Cancer|April 12, 2016
Antitumor Effect of IP-10 by Using Two Different Approaches: Live Delivery System and Gene TherapyYasaman Taslimi, Farnaz Zahedifard, Sima Habibzadeh, et al.
Scientific Reports|May 20, 2026
Bulky pcDNA plasmid encoding Leishmania- and Sandfly-derived antigens resulted in transient Th1 response post Leishmania major infection in BALB/c miceNegar Seyed, Hamzeh Sarvnaz, Sima Habibzadeh, et al.
Pageof 14